120 related articles for article (PubMed ID: 37573704)
1. Impact of skip mediastinal lymph node metastasis on outcomes after resection for primary lung cancer.
Taylor M; Soliman N; Paoletti E; King M; Crosbie PAJ; Granato F
Lung Cancer; 2023 Oct; 184():107341. PubMed ID: 37573704
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
Liu K; Chen HL; You QS; Huang JF; Wang H
Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
[TBL] [Abstract][Full Text] [Related]
4. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
5. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
6. Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non-small-cell Lung Cancer: A Propensity Score Matching Analysis.
Wang L; Zhan C; Gu J; Xi J; Lin Z; Xue L; Ge D; Wang Q
Clin Lung Cancer; 2019 May; 20(3):e346-e355. PubMed ID: 30665872
[TBL] [Abstract][Full Text] [Related]
7. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
8. Skip mediastinal nodal metastases in non-small cell lung cancer.
Tanaka F; Takenaka K; Oyanagi H; Fujinaga T; Otake Y; Yanagihara K; Ito H; Wada H
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1114-20. PubMed ID: 15145018
[TBL] [Abstract][Full Text] [Related]
9. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
[TBL] [Abstract][Full Text] [Related]
10. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
11. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
Ilic N; Petricevic A; Arar D; Kotarac S; Banovic J; Ilic NF; Tripkovic A; Grandic L
J Thorac Oncol; 2007 Nov; 2(11):1018-21. PubMed ID: 17975493
[TBL] [Abstract][Full Text] [Related]
12. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
[TBL] [Abstract][Full Text] [Related]
15. Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes.
Ito M; Yamashita Y; Tsutani Y; Misumi K; Harada H; Miyata Y; Okada M
Clin Lung Cancer; 2013 Nov; 14(6):651-7. PubMed ID: 24188630
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].
Zhang S; Wang L; Lu F; Pei Y; Yang Y
Zhongguo Fei Ai Za Zhi; 2019 Nov; 22(11):702-708. PubMed ID: 31771739
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the current Japanese nodal classification on outcomes in resected non-small cell lung cancer.
Ichinose J; Murakawa T; Hino H; Konoeda C; Inoue Y; Kitano K; Nagayama K; Nitadori JI; Anraku M; Nakajima J
Chest; 2014 Sep; 146(3):644-649. PubMed ID: 24811857
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer.
Gorai A; Sakao Y; Kuroda H; Uehara H; Mun M; Ishikawa Y; Nakagawa K; Masuda M; Okumura S
Eur J Cardiothorac Surg; 2015 Apr; 47(4):653-8. PubMed ID: 24957260
[TBL] [Abstract][Full Text] [Related]
19. Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease.
Wang L; Ye G; Xue L; Zhan C; Gu J; Xi J; Lin Z; Jiang W; Ge D; Wang Q
Clin Lung Cancer; 2020 Sep; 21(5):e423-e434. PubMed ID: 32245623
[TBL] [Abstract][Full Text] [Related]
20. The Significance of Skip Mediastinal Lymph Node Metastasis in the Prognosis of Patients with Resected Non-Small-Cell Lung Carcinoma: Is It Really a Better N2 Disease Subtype?
Seyrek Y; Cansever L; Akın H; Metin M; Bolat E; Bedirhan MA
Ann Thorac Cardiovasc Surg; 2021 Oct; 27(5):304-310. PubMed ID: 33790147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
